1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Smoking Cessation-Pipeline Insights, 2014

Smoking Cessation-Pipeline Insights, 2014

  • August 2014
  • -
  • Delve Insight

SUMMARY
DelveInsight’s,“ Smoking Cessation-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Smoking Cessation. This report provides information on the therapeutic development based on the Smoking Cessation dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Smoking Cessation
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Smoking Cessation pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Smoking Cessation and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Smoking Cessation
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Smoking Cessation pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Smoking Cessation-Pipeline Insights, 2014
Table of Contents
- Smoking Cessation Overview
- Smoking Cessation Pipeline Therapeutics
- Smoking Cessation Therapeutics under Development by Companies
- Smoking Cessation Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Smoking Cessation Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Smoking Cessation Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Smoking Cessation Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Smoking Cessation - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Smoking Cessation - Discontinued Products
- Smoking Cessation - Dormant Products
- Companies Involved in Therapeutics Development for Smoking Cessation
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Smoking Cessation, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Smoking Cessation Assessment by Monotherapy Products
- Smoking Cessation Assessment by Combination Products
- Smoking Cessation Assessment by Route of Administration
- Smoking Cessation Assessment by Stage and Route of Administration
- Smoking Cessation Assessment by Molecule Type
- Smoking Cessation Assessment by Stage and Molecule Type
- Smoking Cessation Therapeutics - Discontinued Products
- Smoking Cessation Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Smoking Cessation, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Smoking Cessation Assessment by Monotherapy Products
- Smoking Cessation Assessment by Combination Products
- Smoking Cessation Assessment by Route of Administration
- Smoking Cessation Assessment by Stage and Route of Administration
- Smoking Cessation Assessment by Molecule Type
- Smoking Cessation Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global and Chinese Smoking Cessation Drugs Industry, 2016 Market Research Report

Global and Chinese Smoking Cessation Drugs Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Smoking Cessation Drugs Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Smoking Cessation Drugs industry ...

2016 Varenicline (Tartrate) (CAS 375815-87-5) Global Market Report

2016 Varenicline (Tartrate) (CAS 375815-87-5) Global Market Report

  • $ 2800
  • Industry report
  • August 2016
  • by Prof Research

The 'Global and Chinese Varenicline (Tartrate) Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Varenicline (Tartrate) industry with a ...

2016 Varenicline Tartrate (CAS 375815-87-5) Global Market Report

2016 Varenicline Tartrate (CAS 375815-87-5) Global Market Report

  • $ 2800
  • Industry report
  • August 2016
  • by Prof Research

The 'Global and Chinese Varenicline Tartrate Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Varenicline Tartrate industry with a focus ...


Download Unlimited Documents from Trusted Public Sources

Cardiovascular Disease Statistics in the US

  • October 2016
    6 pages
  • Cardiovascular ...  

    Salicylic Acid  

    Pain Relief  

  • United States  

    North America  

View report >

Smoking Statistics Industry in Malaysia

  • October 2016
    11 pages
  • Smoking Statist...  

    Smoking Cessati...  

  • Malaysia  

View report >

Pharmacies And Drug Stores Markets in Australia

  • September 2016
    8 pages
  • Pharmacies And ...  

    Healthcare  

    OTC  

  • Australia  

View report >

Pathology Statistics

4 months ago

Otc Industry In The Us

6 months ago

Related Market Segments :

Smoking Cessation

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.